Sickle Cell Disease Drug approved in EU to interfere with Pathogenesis

被引：0
|
作者：
Freye, Reimund
机构：
来源：
ACTA HAEMATOLOGICA | 2022年 / 145卷 / 05期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 573
页数：1
相关论文
共 50 条
  • [21] Hydroxyurea in Sickle Cell Disease: Drug Review
    Agrawal, Rohit Kumar
    Patel, Rakesh Kantilal
    Shah, Varsha
    Nainiwal, Lalit
    Trivedi, Bhadra
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (02) : 91 - 96
  • [22] Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
    Cannon, Matthew
    Phillips, Hannah
    Smith, Sidney
    Williams, Katie
    Brinton, Lindsey
    Gregory, Charles
    Landes, Kristina
    Desai, Payal
    Byrd, John
    Lapalombella, Rosa
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [23] PATHOGENESIS OF HYPOGONADISM ASSOCIATED WITH SICKLE-CELL DISEASE (SSD)
    ABBASI, AA
    PRASAD, AS
    LEI, KY
    ORTEGA, J
    AHMADI, H
    CLINICAL RESEARCH, 1975, 23 (03): : A232 - A232
  • [24] Fibrocytes in the Pathogenesis of Chronic Sickle Cell Lung Disease.
    Burdick, M. D.
    Mehrad, B.
    Field, J. J.
    Wallace, K.
    Liu, L.
    Strieter, B. A.
    Linden, J.
    Strieter, R. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [25] Pathogenesis Of Cardiorespiratory Impairments In A Mouse Model Of Sickle Cell Disease
    MacLean, J. E.
    Ren, J.
    Ding, X.
    Trudel, M.
    Greer, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [26] Role of nitric oxide in the pathogenesis and therapy of sickle cell disease
    Gladwin, MT
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S299 - S299
  • [27] PRESCRIBING TRENDS OF NEWLY APPROVED SICKLE CELL DISEASE-MODIFYING MEDICATIONS
    Zhang, Y.
    Kang, H. A.
    Mignacca, R. C.
    Chang, A.
    VALUE IN HEALTH, 2024, 27 (06) : S227 - S228
  • [28] THE LIFE SPAN OF THE SICKLE CELL AND THE PATHOGENESIS OF SICKLE CELL ANEMIA
    SINGER, K
    ROBIN, S
    KING, JC
    JEFFERSON, RN
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1948, 33 (08): : 975 - 984
  • [29] Pathophysiologically based drug treatment of sickle cell disease
    Steinberg, MH
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (04) : 204 - 210
  • [30] The Evolving Landscape of Drug Therapies for Sickle Cell Disease
    Rai, Parul
    Desai, Payal C.
    Ataga, Kenneth, I
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (06) : 1285 - 1312
12345